scispace - formally typeset
K

Klaus Lieb

Researcher at University of Mainz

Publications -  406
Citations -  18082

Klaus Lieb is an academic researcher from University of Mainz. The author has contributed to research in topics: Borderline personality disorder & Medicine. The author has an hindex of 70, co-authored 363 publications receiving 15327 citations. Previous affiliations of Klaus Lieb include University of Freiburg & Leibniz Association.

Papers
More filters
Journal ArticleDOI

Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial.

TL;DR: The data suggest that three months of inpatient DBT treatment is significantly superior to non-specific outpatient treatment within a relatively short time frame, and improvement was found across a broad range of psychopathological features.
Journal ArticleDOI

The resilience framework as a strategy to combat stress-related disorders

TL;DR: This work highlights challenges to resilience research and makes concrete conceptual and methodological proposals to improve resilience research, and proposes to focus research on the dynamic processes of successful adaptation to stressors in prospective longitudinal studies.
Journal ArticleDOI

Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies.

TL;DR: It is found that concepts, methods and designs in current resilience intervention studies are of limited use to properly assess efficacy of interventions to foster resilience and propose standards for future intervention research based on recent developments in the field.
Journal ArticleDOI

Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.

TL;DR: The current evidence from randomised controlled trials suggests that drug treatment, especially with mood stabilisers and second-generation antipsychotics, may be effective for treating a number of core symptoms and associated psychopathology, but the evidence does not currently support effectiveness for overall severity of borderline personality disorder.